e-ISSN: Pending
Negative / Null Result ReportOpen accessEngineering· cited by 10

Iteration of Tumor Organoids in Drug Development: Simplification and Integration

Rui Zhao; Qiushi Feng; Yangyang Xia; Lingzi Liao; Shang Xie · 2025 · Pharmaceuticals

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

The inherent complexity and heterogeneity of tumors pose substantial challenges for the development of effective oncology therapeutics. Organoids, three-dimensional (3D) in vitro models, have become essential tools for predicting therapeutic responses and advancing precision oncology, with established correlations to clinical outcomes in patient-derived models. These systems have transformed preclinical drug screening by bridging the gap between conventional two-dimensional (2D) cultures and in vivo models, preserving tumor histopathology, cellular heterogeneity, and patient-specific molecular

Abstract by Rui Zhao; Qiushi Feng; Yangyang Xia; Lingzi Liao; Shang Xie, Pharmaceuticals (2025) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.3390/ph18101540